| Patents for A61P 1 - Drugs for disorders of the alimentary tract or the digestive system (125,798) | 
|---|
| 11/27/2008 | WO2008144473A2 Chimeric pufa polyketide synthase systems and uses thereof | 
| 11/27/2008 | WO2008144423A2 Compositions comprising a gpr109 ligand for treating disorders of the digestive tract and/or cancer | 
| 11/27/2008 | WO2008144072A1 Dose forms comprising vx- 950 and their dosage regimen | 
| 11/27/2008 | WO2008143916A2 Prokinetic agent for bowel preparation | 
| 11/27/2008 | WO2008143545A1 Agent for stimulating lymphatic drainage | 
| 11/27/2008 | WO2008143527A1 Probiotic bacterium | 
| 11/27/2008 | WO2008143263A1 1-substituted tetrahydroisoquinoline compound | 
| 11/27/2008 | WO2008143255A1 Method for production of cell population | 
| 11/27/2008 | WO2008143240A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation | 
| 11/27/2008 | WO2008142859A1 Novel spiro-oxindole compound and pharmaceutical containing the same | 
| 11/27/2008 | WO2008142445A1 Process for the preparation of form a of tegaserod | 
| 11/27/2008 | WO2008141989A1 Probiotics in a pre- and/or post surgical environment | 
| 11/27/2008 | WO2008141368A1 Combination laxative compositions comprising a colonic stimulant and a bulking laxative | 
| 11/27/2008 | WO2008046087A3 Spiro compounds and their uses as therapeutic agents | 
| 11/27/2008 | US20080293962 Novel compounds of the N-acylamino amide family compositions comprising them and uses thereof | 
| 11/27/2008 | US20080293818 Regulator of Physiological Function of Ghrelin and Use Thereof | 
| 11/27/2008 | US20080293799 Liver Function Ameliorant | 
| 11/27/2008 | US20080293797 Central nervous system disorders; respiratory system disorders; sexual or reproductive disorders; eating disorders; antidiabetic agents; cardiovascular disorders; anticancer agents | 
| 11/27/2008 | US20080293794 Diaryltriazolmethylamine derivatives, preparation and therapeutic use thereof | 
| 11/27/2008 | US20080293785 Substituted benzothiazole kinase inhibitors | 
| 11/27/2008 | US20080293773 Amorphous Esomeprazole Hydrate | 
| 11/27/2008 | US20080293772 Salts of picotamide | 
| 11/27/2008 | US20080293767 1-Isopropyl-2-Oxo-1,2-Dihydropyridine-3-Carboxamide Derivatives Having 5-Ht4 Receptor Agonistic Activity | 
| 11/27/2008 | US20080293762 Preventive and Therapeutic medicament for gastroesophageal reflux disease | 
| 11/27/2008 | US20080293748 Thioxanthine Derivatives as Myeloperoxidase Inhibitors | 
| 11/27/2008 | US20080293717 Aryl sulfonamides | 
| 11/27/2008 | US20080293670 Edible tremella polysaccharide for prevention and/or improvement of intestinal disorder | 
| 11/27/2008 | US20080293667 Lipid analogs for combating tumors | 
| 11/27/2008 | US20080293658 Antisense oligonucleotides capable of inhibiting the formation of capillary tubes by endothelial cells | 
| 11/27/2008 | US20080293657 Modulation of the expression of stat-1-dependent genes | 
| 11/27/2008 | US20080293650 Fused Heterocyclic Compounds and Use Thereof | 
| 11/27/2008 | US20080293634 C-met receptor regulation by angiotensin iv (at4) receptor ligands | 
| 11/27/2008 | US20080293632 Use of natriuretic peptides for the treatment of stature disorders related to shox gene | 
| 11/27/2008 | US20080292733 Antioxidant and Fe2+ Chelating Properties of Herbal Extracts | 
| 11/27/2008 | US20080292701 Lansoprazole dosage forms; fast disintegration in the oral cavity even without water | 
| 11/27/2008 | US20080292693 Composition and method for treating digestive system disorders | 
| 11/27/2008 | US20080292661 Use of Botulinum Toxin for the Preparation of a Medicament for the Treatment of Lithiasis of Salivary Gland, Gall Bladder, Kidney, or Pancreas | 
| 11/27/2008 | US20080292642 Crystalline anti-human IL-12 antibodies | 
| 11/27/2008 | US20080292610 Medicaments containing enzymes from ciliates for promoting digestion in digestive disorders | 
| 11/27/2008 | US20080292604 Canine probiotic lactobacilli | 
| 11/27/2008 | US20080292581 Interleukin-11 Fusion Proteins | 
| 11/27/2008 | US20080292544 Modified Proteins, Designer Toxins, and Methods of Making Thereof | 
| 11/27/2008 | CA2687958A1 1-substituted tetrahydroisoquinoline compound | 
| 11/27/2008 | CA2687558A1 Oral preparation comprising specific organic acid, and method for improvement in elution property and chemical stability of oral preparation | 
| 11/27/2008 | CA2687545A1 Agent for stimulating lymphatic drainage | 
| 11/27/2008 | CA2687523A1 Chimeric pufa polyketide synthase systems and uses thereof | 
| 11/27/2008 | CA2687209A1 Process for the preparation of form a of tegaserod | 
| 11/27/2008 | CA2686976A1 Probiotics in a pre- and/or post-surgical environment | 
| 11/27/2008 | CA2686686A1 Il-9 in fibrotic and inflammatory disease | 
| 11/27/2008 | CA2685826A1 Prokinetic agent for bowel preparation | 
| 11/27/2008 | CA2684150A1 Induction of a physiological dispersion response in bacterial cells in a biofilm | 
| 11/26/2008 | EP1994940A1 Therapeutic use of a recombinant erythropoietin having high activity and reduced side effects | 
| 11/26/2008 | EP1993544A1 The use of beta-aminoalcohols for the treatment of inflammatory disorders and pain | 
| 11/26/2008 | EP1993525A1 The use of beta-aminoalcohols in the treatment of inflammatory disorders and pain | 
| 11/26/2008 | EP1993376A1 Animal food composition comprising nut shell | 
| 11/26/2008 | EP1496914B1 (20S)-1alpha-HYDROXY-2alpha-METHYL AND 2beta-METHYL-19-NOR-VITAMIN D3 AND THEIR USES | 
| 11/26/2008 | EP1438296B1 1h-imidazole derivatives having cb1 agonistic, cb1 partial agonistic or cb1- antagonistic activity | 
| 11/26/2008 | EP1414455B1 Isoquinoline inhibitors of p38 | 
| 11/26/2008 | EP1370228B1 Systems for delivering a cosmetic and/or therapeutic active to oral surfaces | 
| 11/26/2008 | EP1153609B1 Amino acid-containing albumin preparations | 
| 11/26/2008 | CN101312967A Carbamate compounds as 5-ht4 receptor agonists | 
| 11/26/2008 | CN101312953A Pharmacologically active compounds containing sulfur | 
| 11/26/2008 | CN101312736A Encapsulation system | 
| 11/26/2008 | CN101311173A Herpe-lactone, preparation method and use thereof | 
| 11/26/2008 | CN101310768A Medicine composition for treating hepatic disease and use thereof | 
| 11/26/2008 | CN101310761A Composition for warming the middle energizer and regulating the stomach, preparation method and quality control method thereof | 
| 11/26/2008 | CN101310749A Chinese patent medicines for treating bellyache and gastrosis | 
| 11/26/2008 | CN101310743A Chinese patent medicines for treating gastrotympanites | 
| 11/26/2008 | CN101310723A Use of compounds that are effective as selective opiate receptor modulators | 
| 11/26/2008 | CN100436578C Modulation of the transcription of pro-inflammatory gene products | 
| 11/26/2008 | CN100436477C Cyclic peptide containing arginine, glycine, asparagicacid-sequence and active target liposome | 
| 11/26/2008 | CN100436453C Aryl-substituted diazabicycloalkanes as nicotinic acetylcholine agonists | 
| 11/26/2008 | CN100436452C Pyrazole compounds useful as protein kinase inhibitors | 
| 11/26/2008 | CN100436439C Dimeric isoflavones | 
| 11/26/2008 | CN100436415C Process for the preparation of (R)-& alpha, -(2,3-dimethoxyp-henyl)-1-[2-(4-fluorophenyl)ethyl]-4-piperidinemethanol | 
| 11/26/2008 | CN100436414C Azabicyclo derivatives as muscarinic receptor antagonists | 
| 11/26/2008 | CN100435830C Medicine for treating diarrhoea caused by weakness and cold of spleen and stomach | 
| 11/26/2008 | CN100435818C Medicine for treating bone ulcer | 
| 11/26/2008 | CN100435809C Ginseng bupleurum drop pill for treating liver disease and its preparation method | 
| 11/26/2008 | CN100435807C Pharmaceutical gel composition | 
| 11/26/2008 | CN100435806C Anionic polymers as toxin binders and antibacterial agents | 
| 11/26/2008 | CN100435795C Micro-powder dom peridone maleate medicinal composition and its preparing method | 
| 11/26/2008 | CN100435791C Solid bicyclic alcohol dispersion | 
| 11/26/2008 | CN100435790C EGCG-zinc complex solid dispersion, its preparation method and application | 
| 11/26/2008 | CN100435785C Methods and compounds for inhibiting amyloid deposits | 
| 11/26/2008 | CN100435663C Health-care food with functions of improving immunocompetence and protecting damaged gastric mucosa and its preparing method | 
| 11/25/2008 | US7456253 Growth hormone releasing peptides | 
| 11/25/2008 | US7456217 Administering N-(2,6-Dichlorobenzoyl)-4-(2,6-dimethoxy-4-methoxymethylphenyl)-L-phenylalanine ethyl ester for therapy of multiple sclerosis | 
| 11/25/2008 | US7456182 Phenylpiperazines | 
| 11/25/2008 | US7456158 4-dedimethylaminotetracycline derivatives | 
| 11/25/2008 | US7456157 Modulate sphingosine-1-phosphate (S1P) receptors with fewer side effects; for example, 2-amino-5-[4-(3-benzyloxyphenylthio)-2-chlorophenyl]-2-methylpentylphosphonic acid monoester; prophylactic or therapeutic agents against rejection of organ transplants, skin grafts, rheumatoid arthritis, lupus | 
| 11/25/2008 | US7456155 2′-C-methyl-3′-O-L-valine ester ribofuranosyl cytidine for treatment of flaviviridae infections | 
| 11/25/2008 | US7455839 Method of inhibiting the formation of inhibin/betaglycan complexes with an anti-betaglycan antibody | 
| 11/25/2008 | US7455835 Administering soluble cytotoxic t-lymphocyte associated antigen (ctla4) molecule that binds a cell surface B7 molecule | 
| 11/25/2008 | CA2433878C Nucleoside derivatives as inhibitors of rna-dependent rna viral polymerase | 
| 11/25/2008 | CA2376791C Drug delivery device for insertion in the vagina, rectum or nasal cavity | 
| 11/25/2008 | CA2367666C Method of treating eating disorders | 
| 11/25/2008 | CA2362211C Benzamide derivatives and medicament containing the same | 
| 11/25/2008 | CA2306508C Production of a directly compressible tabletting aid | 
| 11/25/2008 | CA2224369C Aromatic acid diamides with antigastrin activity, a method for their preparation and their pharmaceutical use |